Shares of Oklo (OKLO 6.58%) are soaring today, up 5.7% as of 1:33 p.m. ET. The jump comes as the S&P 500 and Nasdaq Composite both moved higher.While there isn't a specific catalyst today, the company's stock is continuing to rise after an important announcement last week and broader momentum in the nuclear industry.Oklo is teaming up with the Air ForceThe company, which develops advanced small nuclear reactors (SMRs), announced last week that it has been "conditionally" selected to provide power to an Air ...

Key Takeaways CLX's streamlined model aims to enhance technology and support agile, sustainable growth. CLX's productivity efforts include ERP upgrades, digital tools and streamlined operations. FY25 gross margin is expected to rise 150 bps, helping counter rising trade and tariff costs.The Clorox Company’s (CLX) productivity mechanism plays a pivotal role in its strategic execution and operational excellence. The company advances its productivity agenda by leveraging digital tools, empowering the workfor ...

Key Takeaways ABM's Q2 EPS of $0.86 missed estimates and declined 1.2% year over year, sparking a 12.3% stock drop. ABM forecasts FY25 EPS of $3.65-$3.80, with the mid-point below the current consensus estimate of $3.74. Top line rose 4.6% to $2.1B, beating estimates, driven by the aviation and technical solutions segments.ABM (ABM) reported mixed second-quarter fiscal 2025 results. Earnings per share (EPS) missed the Zacks Consensus Estimate, while revenues beat the same.Dismal earnings results and weak ...

Key Takeaways Carlyle will collaborate with Citigroup to grow asset-backed finance in fintech specialty lending. The partnership unites Carlyle's investment reach with Citigroup's SPRINT fintech expertise. Both firms will share market insights and co-invest to meet the rising fintech lender funding demand.Carlyle Group Inc. (CG) has announced a collaboration with Citigroup Inc. (C) to expand asset-backed financing opportunities within the fintech specialty lending space.Details of the Partnership Between ...

When last I wrote about C4 Therapeutics (NASDAQ: CCCC ) a few months ago , my headline stated that the stock is getting "too cheap to ignore," but this did not ascend toI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investing in this space.Analyst’s Disclosure ...

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying strong candidates involves navigating inherent risks and volatility [1] Group 1: Company Overview - New Jersey Resources (NJR) is currently highlighted as a promising growth stock, supported by a favorable Growth Score and a top Zacks Rank [2] - The company has a historical EPS growth rate of 9.6%, with projected EPS growth of 9.9% this year, surpassing the industry average of 9.2% [4] Group 2: Financial Metrics - NJR's year-over-year cash flow growth stands at 10.3%, significantly higher than the industry average of -0.1% [5] - The historical annualized cash flow growth rate for NJR over the past 3-5 years is 12.3%, compared to the industry average of 7.2% [6] Group 3: Earnings Estimates - There is a positive trend in earnings estimate revisions for NJR, with the current-year earnings estimates increasing by 0.8% over the past month [7] - NJR has achieved a Zacks Rank of 2 (Buy) due to favorable earnings estimate revisions and a Growth Score of B [8] Group 4: Investment Potential - The combination of strong growth metrics and positive earnings revisions positions NJR well for potential outperformance, making it an attractive option for growth investors [9]

Group 1 - Permian Resources announced another acquisition during the first quarter earnings press release, indicating ongoing growth and expansion strategies [2] - The revised guidance provided by Permian Resources did not account for the latest acquisition, suggesting potential for further adjustments in future forecasts [2] - The oil and gas industry is characterized as a boom-bust, cyclical sector, requiring patience and experience for successful investment [2] Group 2 - The analysis of oil and gas companies focuses on identifying undervalued names within the sector, examining balance sheets, competitive positions, and development prospects [1] - Members of the Oil & Gas Value Research service receive early access to analyses and insights that are not available on the free site [1]

Core Insights - SkyWater Technology's Wafer Services revenues experienced a 25% year-over-year decline in Q1 FY25 due to decreased demand from automotive customers, but a strong sequential rebound of 70% to $7.5 million was driven by the launch of the ThermaView platform [2][9] - ThermaView, SkyWater's first internally developed product platform for thermal imaging, is already being deployed by two major U.S. defense contractors, indicating its significance in mission-critical applications [3][9] - The company anticipates that ThermaView will be a key growth driver for Wafer Services through FY25, addressing a projected $9 billion market opportunity by 2027 [4][5] Financial Performance - For Q2 FY25, SkyWater expects Wafer Services revenues to be between $5 million and $6 million, reflecting ongoing demand for ThermaView [4][9] - SkyWater's shares have declined by 40.6% year-to-date, contrasting with the Zacks Electronics – Semiconductors industry's return of 3.9% [8] - The current forward 12-month price-to-sales ratio for SkyWater is 1.17, significantly lower than the industry average of 8X, making it an attractive option for value investors [10] Earnings Estimates - The Zacks Consensus Estimate for SkyWater's 2025 loss is currently at 1 cent per share, which has narrowed by 85.7% over the past 60 days, indicating a year-over-year decline of 116.67% [11] - Earnings estimates for the upcoming quarters show a projected loss of $0.17 for the current quarter, a profit of $0.09 for the next quarter, and a loss of $0.01 for the current year [12] Competitive Landscape - SkyWater faces significant competition from GlobalFoundries, which offers a wide range of process technologies and serves diverse markets, holding advantages in scale and capacity [6] - Tower Semiconductor specializes in analog, RF, and MEMS technologies, targeting high-value niches and offering customizable solutions, which positions it as a strong competitor in complex analog projects [7]

Key Takeaways SKYT is gaining traction through new tech platforms, quantum projects and the Fab 25 acquisition plan. SKYT's forward P/S of 1.17X and value score of B make it attractive versus MRVL's 6.61X and value score of D. MRVL faces margin pressure from lower-margin custom silicon and softness in industrial segments.SkyWater Technology (SKYT) and Marvell Technology (MRVL) are both active players in the semiconductor space, with SKYT focusing on specialty foundry services and MRVL leading in custom si ...

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Vestis Corporation (NYSE: VSTS) between May 2, 2024 and May 6, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 8, 2025. SO WHAT: If you purchased Vestis securities during the Class Period yo ...